Hai-yan Sun
Shijiazhuang, 050011, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Prognostic value of stromal CD39+CD8+ T cells in predicting platinum sensitivity and survival outcomes in epithelial ovarian cancer.
Journal: Scientific reports
Published: December 06, 2024
Evolution of lymphovascular space invasion in early-stage endometrial carcinoma: stratification, quantification, and clinical implications: a systematic review.
Journal: Archives of gynecology and obstetrics
Published: November 17, 2024
Corrigendum: High expression of PARP1 in tumor and stroma cells predicts prognosis and platinum resistance in patients with advanced epithelial ovarian cancer.
Journal: Frontiers in oncology
Published: May 08, 2023
High Expression of PARP1 in Tumor and Stroma Cells Predicts Different Prognosis and Platinum Resistance in Patients With Advanced Epithelial Ovarian Cancer.
Journal: Frontiers in oncology
Published: April 29, 2022
Promoter Methylation of the MGRN1 Gene Predicts Prognosis and Response to Chemotherapy of High-Grade Serous Ovarian Cancer Patients.
Journal: Frontiers in oncology
Published: January 27, 2021
DNA repair gene associated with clinical outcome of epithelial ovarian cancer treated with platinum-based chemotherapy.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: April 30, 2013
nm23 gene polymorphisms are associated with survival of patients with epithelial ovarian cancer but not with susceptibility to disease.
Journal: Gynecologic oncology
Published: May 10, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026